RIVFLOZA Trademark

Trademark Overview

On Friday, September 18, 2020, a trademark application was filed for RIVFLOZA with the United States Patent and Trademark Office. The USPTO has given the RIVFLOZA trademark a serial number of 90191150. The federal status of this trademark filing is REGISTERED as of Tuesday, August 20, 2024. This trademark is owned by Dicerna Pharmaceuticals, Inc.. The RIVFLOZA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of various diseases, namely, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of RNAi therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Scientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
rivfloza

General Information

Serial Number90191150
Word MarkRIVFLOZA
Filing DateFriday, September 18, 2020
Status700 - REGISTERED
Status DateTuesday, August 20, 2024
Registration Number7482490
Registration DateTuesday, August 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of various diseases, namely, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of RNAi therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Goods and ServicesScientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2020
Primary Code005
First Use Anywhere DateTuesday, March 19, 2024
First Use In Commerce DateTuesday, March 19, 2024
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2020
Primary Code042
First Use Anywhere DateTuesday, March 19, 2024
First Use In Commerce DateTuesday, March 19, 2024

Trademark Owner History

Party NameNOVO NORDISK HEALTH CARE AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressZürich CH-8058
CH
Party NameNOVO NORDISK HEALTH CARE AG
Party Type21 - New Owner After Publication
Legal Entity Type25 - NOT AVAILABLE
AddressZürich CH-8058
CH
Party NameDicerna Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameDicerna Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Tuesday, September 22, 2020NEW APPLICATION ENTERED
Tuesday, October 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 3, 2021ASSIGNED TO EXAMINER
Thursday, February 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 3, 2021PRIORITY ACTION WRITTEN
Wednesday, February 3, 2021PRIORITY ACTION E-MAILED
Wednesday, February 3, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, February 25, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 25, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 31, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 2, 2021FINAL REFUSAL WRITTEN
Monday, August 2, 2021FINAL REFUSAL E-MAILED
Monday, August 2, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 2, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 3, 2022SOU EXTENSION 1 FILED
Thursday, November 3, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 3, 2023SOU EXTENSION 2 FILED
Wednesday, May 3, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 3, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2024SOU EXTENSION 4 GRANTED
Thursday, October 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 19, 2023SOU EXTENSION 3 FILED
Thursday, October 19, 2023SOU EXTENSION 3 GRANTED
Saturday, October 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 3, 2024SOU EXTENSION 4 FILED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 8, 2024USE AMENDMENT FILED
Wednesday, May 8, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, June 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 13, 2024STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

rivfloza delivery compounds drug agents scientific diseases preparations pharmaceutical research nature